Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) Gross Margin (2016 - 2026)

Bio-Techne has reported Gross Margin over the past 17 years, most recently at 64.65% for Q4 2025.

  • For Q4 2025, Gross Margin fell 63.0% year-over-year to 64.65%; the TTM value through Dec 2025 reached 65.22%, down 41.0%, while the annual FY2025 figure was 64.8%, 161.0% down from the prior year.
  • Gross Margin for Q4 2025 was 64.65% at Bio-Techne, down from 65.65% in the prior quarter.
  • Over five years, Gross Margin peaked at 8979.75% in Q3 2022 and troughed at 62.72% in Q2 2025.
  • A 5-year average of 512.46% and a median of 67.47% in 2022 define the central range for Gross Margin.
  • Biggest five-year swings in Gross Margin: skyrocketed 891340bps in 2022 and later tumbled -891288bps in 2023.
  • Year by year, Gross Margin stood at 68.22% in 2021, then dropped by -1bps to 67.52% in 2022, then decreased by -4bps to 64.78% in 2023, then rose by 1bps to 65.27% in 2024, then decreased by -1bps to 64.65% in 2025.
  • Business Quant data shows Gross Margin for TECH at 64.65% in Q4 2025, 65.65% in Q3 2025, and 62.72% in Q2 2025.